801 related articles for article (PubMed ID: 35019723)
21. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
[TBL] [Abstract][Full Text] [Related]
22. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
Mondal T; Shivange G; Habieb A; Tushir-Singh J
Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
[TBL] [Abstract][Full Text] [Related]
23. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
[TBL] [Abstract][Full Text] [Related]
24. The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.
Zou W; Xiong M; Hao S; Zhang EY; Baumlin N; Kim MD; Salathe M; Yan Z; Qiu J
mBio; 2021 May; 12(3):. PubMed ID: 33975939
[TBL] [Abstract][Full Text] [Related]
25. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
[TBL] [Abstract][Full Text] [Related]
26. Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways.
Iwata-Yoshikawa N; Kakizaki M; Shiwa-Sudo N; Okura T; Tahara M; Fukushi S; Maeda K; Kawase M; Asanuma H; Tomita Y; Takayama I; Matsuyama S; Shirato K; Suzuki T; Nagata N; Takeda M
Nat Commun; 2022 Oct; 13(1):6100. PubMed ID: 36243815
[TBL] [Abstract][Full Text] [Related]
27. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA
J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890
[TBL] [Abstract][Full Text] [Related]
28. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
Kishimoto M; Uemura K; Sanaki T; Sato A; Hall WW; Kariwa H; Orba Y; Sawa H; Sasaki M
Viruses; 2021 Feb; 13(3):. PubMed ID: 33671076
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.
Sasaki M; Uemura K; Sato A; Toba S; Sanaki T; Maenaka K; Hall WW; Orba Y; Sawa H
PLoS Pathog; 2021 Jan; 17(1):e1009233. PubMed ID: 33476327
[TBL] [Abstract][Full Text] [Related]
30. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
Ogando NS; Dalebout TJ; Zevenhoven-Dobbe JC; Limpens RWAL; van der Meer Y; Caly L; Druce J; de Vries JJC; Kikkert M; Bárcena M; Sidorov I; Snijder EJ
J Gen Virol; 2020 Sep; 101(9):925-940. PubMed ID: 32568027
[TBL] [Abstract][Full Text] [Related]
31. Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells.
Aiewsakun P; Phumiphanjarphak W; Ludowyke N; Purwono PB; Manopwisedjaroen S; Srisaowakarn C; Ekronarongchai S; Suksatu A; Yuvaniyama J; Thitithanyanont A
Genome Biol Evol; 2023 Apr; 15(4):. PubMed ID: 36852863
[TBL] [Abstract][Full Text] [Related]
32. Propagation of SARS-CoV-2 in Calu-3 Cells to Eliminate Mutations in the Furin Cleavage Site of Spike.
Baczenas JJ; Andersen H; Rashid S; Yarmosh D; Puthuveetil N; Parker M; Bradford R; Florence C; Stemple KJ; Lewis MG; O'Connor SL
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960703
[TBL] [Abstract][Full Text] [Related]
33. QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis.
Vu MN; Lokugamage KG; Plante JA; Scharton D; Bailey AO; Sotcheff S; Swetnam DM; Johnson BA; Schindewolf C; Alvarado RE; Crocquet-Valdes PA; Debbink K; Weaver SC; Walker DH; Russell WK; Routh AL; Plante KS; Menachery VD
Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2205690119. PubMed ID: 35881779
[TBL] [Abstract][Full Text] [Related]
34. A second functional furin site in the SARS-CoV-2 spike protein.
Zhang Y; Zhang L; Wu J; Yu Y; Liu S; Li T; Li Q; Ding R; Wang H; Nie J; Cui Z; Wang Y; Huang W; Wang Y
Emerg Microbes Infect; 2022 Dec; 11(1):182-194. PubMed ID: 34856891
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 variants reveal features critical for replication in primary human cells.
Pohl MO; Busnadiego I; Kufner V; Glas I; Karakus U; Schmutz S; Zaheri M; Abela I; Trkola A; Huber M; Stertz S; Hale BG
PLoS Biol; 2021 Mar; 19(3):e3001006. PubMed ID: 33760807
[TBL] [Abstract][Full Text] [Related]
36. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
[TBL] [Abstract][Full Text] [Related]
37. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
Meng B; Abdullahi A; Ferreira IATM; Goonawardane N; Saito A; Kimura I; Yamasoba D; Gerber PP; Fatihi S; Rathore S; Zepeda SK; Papa G; Kemp SA; Ikeda T; Toyoda M; Tan TS; Kuramochi J; Mitsunaga S; Ueno T; Shirakawa K; Takaori-Kondo A; Brevini T; Mallery DL; Charles OJ; ; ; ; Bowen JE; Joshi A; Walls AC; Jackson L; Martin D; Smith KGC; Bradley J; Briggs JAG; Choi J; Madissoon E; Meyer KB; Mlcochova P; Ceron-Gutierrez L; Doffinger R; Teichmann SA; Fisher AJ; Pizzuto MS; de Marco A; Corti D; Hosmillo M; Lee JH; James LC; Thukral L; Veesler D; Sigal A; Sampaziotis F; Goodfellow IG; Matheson NJ; Sato K; Gupta RK
Nature; 2022 Mar; 603(7902):706-714. PubMed ID: 35104837
[TBL] [Abstract][Full Text] [Related]
38. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
Lista MJ; Winstone H; Wilson HD; Dyer A; Pickering S; Galao RP; De Lorenzo G; Cowton VM; Furnon W; Suarez N; Orton R; Palmarini M; Patel AH; Snell L; Nebbia G; Swanson C; Neil SJD
J Virol; 2022 Dec; 96(23):e0125022. PubMed ID: 36350154
[TBL] [Abstract][Full Text] [Related]
39. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells.
Matsuyama S; Shirato K; Kawase M; Terada Y; Kawachi K; Fukushi S; Kamitani W
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021905
[TBL] [Abstract][Full Text] [Related]
40. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.
Papa G; Mallery DL; Albecka A; Welch LG; Cattin-Ortolá J; Luptak J; Paul D; McMahon HT; Goodfellow IG; Carter A; Munro S; James LC
PLoS Pathog; 2021 Jan; 17(1):e1009246. PubMed ID: 33493182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
